Lingbao Kong

Dr. Lingbao Kong


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Antiviral Research
Verified
Journal Article
Closed access
LKLingbao Kong
Lingbao Kong
SLShanshan Li
Shanshan Li
QLQingjiao Liao
Qingjiao Liao
YZYanni Zhang
Yanni Zhang
RSRuina Sun
Ruina Sun
YZYing Zhu
Ying Zhu

16 July 2013 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
PDF file
SLShanshan Li
Shanshan Li
LKLingbao Kong
Lingbao Kong
XYXilan Yu
Xilan Yu
The endoplasmic reticulum (ER) is a cellular membrane organelle that plays important roles in virus replication and maturation. Accumulating evidence indicates that virus infection often disturbs ER homeostasis and leads to ER stress, which is associated with a variety of prevalent diseases. To cope with the deleterious effects of virus-induced ER stress, cells activate critical signaling pathways including the unfolded protein response (UPR) and intrinsic mitochondrial apoptosis, which have complex effects on virus replication and pathogenesis. In this review, we present a comprehensive summary of recent research in this field, which revealed that about 36 viruses trigger ER stress and differentially activate ER stress-related signaling pathways. We also highlight the strategies evolved by viruses to modulate ER stress-related signaling networks including immune responses in order to ensure their survival and pathogenesis. Together, the knowledge gained from this field will shed light on unveiling the mechanisms of virus replication and pathogenesis and provide insight for future research as well as antiviral development.

12 December 2015 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
MHMingjie Huang
Mingjie Huang
AXAhui Xu
Ahui Xu
XWXiaoyu Wu
Xiaoyu Wu
YZYanni Zhang
Yanni Zhang
YGYunli Guo
Yunli Guo
LKLingbao Kong
Lingbao Kong

4 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YWYu Wei
Yu Wei
JLJinlong Li
Jinlong Li
JQJie Qing
Jie Qing
MHMingjie Huang
Mingjie Huang
MWMing Wu
Ming Wu
Jianping LinJianping Lin
Jianping Lin
The NS5B polymerase is one of the most attractive targets for developing new drugs to block Hepatitis C virus (HCV) infection. We describe the discovery of novel potent HCV NS5B polymerase inhibitors by employing a virtual screening (VS) approach, which is based on random forest (RB-VS), e-pharmacophore (PB-VS), and docking (DB-VS) methods. In the RB-VS stage, after feature selection, a model with 16 descriptors was used. In the PB-VS stage, six energy-based pharmacophore (e-pharmacophore) models from different crystal structures of the NS5B polymerase with ligands binding at the palm I, thumb I and thumb II regions were used. In the DB-VS stage, the Glide SP and XP docking protocols with default parameters were employed. In the virtual screening approach, the RB-VS, PB-VS and DB-VS methods were applied in increasing order of complexity to screen the InterBioScreen database. From the final hits, we selected 5 compounds for further anti-HCV activity and cellular cytotoxicity assay. All 5 compounds were found to inhibit NS5B polymerase with IC50 values of 2.01–23.84 μM and displayed anti-HCV activities with EC50 values ranging from 1.61 to 21.88 μM, and all compounds displayed no cellular cytotoxicity (CC50 > 100 μM) except compound N2, which displayed weak cytotoxicity with a CC50 value of 51.3 μM. The hit compound N2 had the best antiviral activity against HCV, with a selective index of 32.1. The 5 hit compounds with new scaffolds could potentially serve as NS5B polymerase inhibitors through further optimization and development.

5 March 2012 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
SLShanshan Li
Shanshan Li
XYXilan Yu
Xilan Yu
YGYunli Guo
Yunli Guo
LKLingbao Kong
Lingbao Kong
Hepatitis C virus (HCV) is an important human pathogen infecting more than 170 million people worldwide with approximately three million new cases each year. HCV depends heavily on interactions between viral proteins and host factors for its survival and propagation. Among HCV viral proteins, the HCV non‐structural protein 4B (NS4B) has been shown to mediate virus–host interactions that are essential for HCV replication and pathogenesis and emerged as the target for anti‐HCV therapy. Here, we reviewed recent knowledge about the NS4B interaction networks with host factors and its possible regulatory mechanisms, which will both advance our understanding of the role of NS4B in HCV life cycle and illuminate potential viral and host therapeutic targets.

21 February 2014 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
SLShanshan Li
Shanshan Li
LKLingbao Kong
Lingbao Kong
XYXilan Yu
Xilan Yu
YZYi Zheng
Yi Zheng